Concepedia

Bernadette Brzezicha

BB

Statistics

Publications

3

Citations

157

H-Index

3

Active since

2014

Affiliations

Max Delbrück Center(Current)

Charité - Universitätsmedizin Berlin

Helios Hospital Berlin-Buch

Humboldt-Universität zu Berlin

Freie Universität Berlin

Bernadette Brzezicha is an author at Max Delbrück Center specializing in oncology, cancer immunotherapy, and molecular oncology.

Publications per year

2014–2022

3

Publications

3

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

Uta M. Demel, Marlitt Böger, Schayan Yousefian et al. · Journal of Clinical Investigation · 2022 · 84 citations · Full text

, , +17

A comprehensively characterized large panel of head and neck cancer patient‐derived xenografts identifies the m<scp>TOR</scp> inhibitor everolimus as potential new treatment option

Konrad Klinghammer, J.D. Raguse, Thomas Plath et al. · International Journal of Cancer · 2014 · 60 citations

, , +17

High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies

Özcan Çınar, Bernadette Brzezicha, Corinna Grunert et al. · Journal for ImmunoTherapy of Cancer · 2021 · 13 citations · Full text

, , +17

1–3 of 3